First Turn Management »

Alphatec Holdings shares owned by First Turn Management

Quarter-by-quarter ownership of Alphatec Holdings (ATEC) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Alphatec Holdings

Tip: Access up to 7 years of quarterly data

All positions including Alphatec Holdings held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alphatec Holdings by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 991k 13.79

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Alphatec Holdings

BlackRock
Vanguard Group
First Light Asset Management
Millennium Management
American Century Companies
Jpmorgan Chase & Co
Fred Alger Management
Alyeska Investment Group
Geode Capital Management
Bnp Paribas Investment Partners
Point72 Asset Management
HPM Partners
Royal Bank of Canada
Citadel Advisors
Nuveen Asset Management

View all funds holding Alphatec Holdings